EDGAR Filing Documents for 0001193125-19-009410

Form 8-K - Current report:

SEC Accession No. 0001193125-19-009410

Filing Date

2019-01-15

Accepted

2019-01-15 07:55:35

Documents

Period of Report

2019-01-11

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d684051d8k.htm	8-K	24044
2	EX 4.1	d684051dex41.htm	EX-4.1	7394
3	EX 4.2	d684051dex42.htm	EX-4.2	37978
4	EX 4.3	d684051dex43.htm	EX-4.3	47909
5	EX 10.1	d684051dex101.htm	EX-10.1	14439
6	EX-99.1	d684051dex991.htm	EX-99.1	15330
7	GRAPHIC	g684051g0114212457096.jpg	GRAPHIC	4611
	Complete submission text file	0001193125-19-009410.txt		155095

Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071

Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186

GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)